News

ABF scientist Héctor García Martín is leading research that merges AI, mathematical modeling, and robotics with synthetic biology.

The Agile BioFoundry and seqWell are partnering to develop cost-effective, high-throughput workflows to accelerate strain engineering for biomanufacturing.

ABF and Kiverdi developed a set of genetic tools to improve the genetic engineering efficiency of a chemoautotrophic bacterium, advancing it as a microbial host that can directly convert carbon dioxide into valuable products. 

The ABF and UC Berkeley have demonstrated a high-throughput platform that leverages polyketide synthase enzymes to produce commodity chemicals and precursors to novel materials. 

Join us on April 10 at a workshop led by early-career Agile BioFoundry researchers to learn more about the Agile BioFoundry, what it’s like to work in synthetic biology/biomanufacturing, and career advancement opportunities.

The approach can generate the building blocks needed to develop synthetic genetic tools for algae biomanufacturing.

Our FY17-FY22 Impact Report outlines the Agile BioFoundry's activities and achievements for its first six years of operation.

Hear technical insights from ABF experts on biomanufacturing technologies that accelerate bioproduct R&D.

The process successfully scaled up by ABF and ABPDU produces a precursor to acrylic acid, widely used across the consumer product industry.

The project aims to enable the full-scale adoption of biofoundry applications in society, leveraging the expertise of successful biofoundries.